In line with the results obtained by Chen et al. [89], these authors found reduced in vivo growth of the breast cancer cells injected in fat-1 mice, and an inhibition of HER-2 pathway, demonstrated by the marked decrease of HER2 expression in the tumor tissues growing in fat-1 mice. Here, ERBB2 is linked to breast carcinoma.